Clinical trial
Immediate Versus Criterion-triggered Semaglutide for Suboptimal Clinical Response One Year After Primary Metabolic and Bariatric Surgery: a Randomized, Double-blind Strategy Trial
NCT07859189 is registered in ClinicalTrials.gov with General Committee of Teaching Hospitals and Institutes, Egypt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immediate Versus Criterion-triggered Semaglutide for Suboptimal Clinical Response One Year After Primary Metabolic and Bariatric Surgery: a Randomized, Double-blind Strategy Trial
- Lead sponsor
- General Committee of Teaching Hospitals and Institutes, Egypt
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- October 31, 2028
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
morbid obesity